Amesite Announces NurseMagic™ Meets HIPAA Requirements for Individuals Users, in Addition to Enterprises
Rhea-AI Summary
Amesite Inc. (NASDAQ: AMST) announced that its NurseMagic™ platform now meets HIPAA requirements for all users, both individual and enterprise. The platform enables healthcare providers to securely store and handle patient information through Business Associate Agreements (BAA).
NurseMagic™, launched in June 2024, has expanded to users across all 50 U.S. States and 21 countries, serving professionals in over 130 different healthcare roles. The platform allows users to integrate documentation with any electronic medical record (EMR) system, leveraging AI capabilities to improve efficiency.
The company reports positive traction in both B2B and B2C sales, with the healthcare software-as-a-service market projected to reach over $90 Billion by 2033 at nearly 11% CAGR.
Positive
- Platform now HIPAA-compliant for all users, expanding market reach
- Presence in all 50 U.S. states and 21 countries
- Growing B2B and B2C recurring revenue streams
- Integration capability with any EMR system
Negative
- None.
Insights
NurseMagic's HIPAA compliance for individuals expands addressable market, enabling growth in both enterprise and direct-to-provider channels.
The expansion of NurseMagic's HIPAA compliance from enterprise-only to include individual healthcare providers represents a strategic market expansion. By offering Business Associate Agreements (BAAs) to individual users, Amesite has removed a critical regulatory barrier that previously adoption to enterprise customers only.
This enhancement addresses a key workflow challenge in healthcare. Individual providers can now securely enter protected health information (PHI) into NurseMagic and transfer documentation to any electronic medical record system. This integration approach is particularly valuable in healthcare's fragmented IT ecosystem, where complete platform switching is often impractical.
The adoption across 130 different healthcare roles - including RNs, Nurse Practitioners, Paramedics, and Hospital Managers - demonstrates broad utility. The company launched NurseMagic in June 2024 and has rapidly expanded to users across all 50 U.S. states and 21 countries within its first year.
Amesite is targeting a healthcare SaaS market projected to reach
Expanded HIPAA compliance unlocks direct-to-provider market, potentially accelerating revenue growth for micro-cap Amesite's AI nurse assistant.
Amesite's expansion of HIPAA compliance to individual users creates a dual revenue stream opportunity for their NurseMagic product. The company previously reported increased B2B sales after achieving enterprise HIPAA compliance last year, suggesting this individual-focused enhancement could drive similar growth in the B2C channel.
This development effectively doubles NurseMagic's addressable market without requiring significant additional product development. For a micro-cap company with approximately
The recurring revenue model is particularly significant. NurseMagic operates as a subscription service, which typically generates more predictable and stable revenue than one-time purchases. Management explicitly mentioned "building recurring revenue" through both B2B and B2C sales channels.
While no specific revenue figures were provided, the company's rapid geographic expansion to all 50 states and 21 countries less than a year after launch demonstrates initial market acceptance. This healthcare-specific application leverages Amesite's existing AI expertise from their academic and business segments, allowing them to enter a specialized vertical market while utilizing their core technological capabilities.
NurseMagic™ Now Supports Healthcare Workers in Any Care Setting, Allowing Every Provider to Store Confidential Patient Information
DETROIT, April 22, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced NurseMagic™ now meets HIPAA requirements for all users. This extension ensures that all usage—individual or enterprise—meets regulatory standards for handling sensitive healthcare information. Amesite announced that it met HIPAA requirements for enterprises late last year, and subsequently reported increased sales in B2B.
To meet HIPAA requirements, care providers are required to execute a Business Associate Agreement (BAA) with their software vendors. NurseMagic™ now provides a BAA for all users, whether licenses are purchased by enterprises or by individuals. Any provider can confidently enter patient details or other personally identifiable health information (PHI) into NurseMagic™’s safe, secure environment. Users can copy and paste documentation produced with NurseMagic™ into any electronic medical record (EMR) system, enabling them to take advantage of NurseMagic™’s AI capabilities, no matter their current software infrastructure.
“Meeting HIPAA requirements for all of our users is a natural extension of what we’ve already provided to enterprise customers,” said Kalie Wortinger, Senior Manager of Engineering at Amesite. “We operate in a highly regulated industry, where protecting sensitive data is essential. This expansion reinforces our commitment to trust, privacy, and long-term value—for individual users, organizations, and their patients.”
“We believe that NurseMagic™'s usage by professionals in more than 130 different roles—from Registered Nurses and Nurse Practitioners to Paramedics, Medical Directors, and Hospital Managers—demonstrates the real-world impact of our solution in empowering healthcare workers to enhance care delivery, and meet diverse demands in the industry,” said Sai Nittala, Senior AI Manager at Amesite.
“We believe we have good traction in both B2B and B2C sales, growing our user base and building recurring revenue. As Amesite's AI tools are deployed across healthcare, we expect to lead the industry in reducing documentation burden and improving care team efficiency,” said Dr. Ann Marie Sastry, CEO of Amesite.
Amesite launched NurseMagic™ less than a year ago in June of 2024, leveraging its successes globally in academic and business segments, and quickly generated users across all 50 U.S. States and 21 countries. The app has garnered top reviews and testimonials. Amesite has since announced successful launches of Automated Enterprise Sales Flow, Enterprise Sales to Large Franchisees and Paid Consumer Subscriptions. The healthcare software-as-a-service market is expected to reach a revenue of over
For more information on NurseMagic™, visit www.nursemagic.ai
About Amesite
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
ir@amesite.com
FAQ
What are the key features of Amesite's NurseMagic™ HIPAA compliance update in 2025?
How widespread is the adoption of AMST's NurseMagic™ platform since its June 2024 launch?
What is the market potential for AMST's healthcare software solutions?
How does NurseMagic™ integrate with existing healthcare systems?
